CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 175,349	$ 197,032
Investments	330,933	215,373
Accounts receivable, net	131,660	47,326
Contract assets	44,620	48,189
Other current assets	34,579	39,259
TOTAL CURRENT ASSETS	717,141	547,179
Property, plant and equipment, net	14,147	11,021
Goodwill	28,033	28,033
Intangible assets, net	1,924	2,217
Deferred taxes, net	1,254	2,259
Right-of-use and other assets	6,365	7,520
TOTAL ASSETS	768,864	598,229
CURRENT LIABILITIES
Accounts payable	87,085	39,485
Accrued expenses	78,393	81,721
Contract liabilities	270,686	181,054
TOTAL CURRENT LIABILITIES	436,164	302,260
Noncurrent liabilities	3,996	5,030
TOTAL LIABILITIES	440,160	307,290
COMMITMENTS AND CONTINGENCIES (see Notes 8 and 9)
STOCKHOLDERS' EQUITY
Preferred stock, par value $0.10 per share - 500,000 shares authorized; no shares issued and outstanding
Common stock, par value $0.15 per share - 30,000,000 shares authorized; 15,828,289 shares issued; 13,569,104 and 13,242,520 shares outstanding at October 31, 2024 and January 31, 2024, respectively	2,374	2,374
Additional paid-in capital	168,441	164,183
Retained earnings	266,334	225,507
Treasury stock, at cost - 2,259,185 and 2,585,769 shares at October 31, 2024 and January 31, 2024, respectively	(102,746)	(97,528)
Accumulated other comprehensive loss	(5,699)	(3,597)
TOTAL STOCKHOLDERS' EQUITY	328,704	290,939
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 768,864	$ 598,229